Article
A baseline transcriptional signature associates with clinical malaria risk in RTS,S/AS01-vaccinated African children
2021-05-19
Abstract excerpt
In a phase 3 trial in African infants/children, the RTS,S/AS01 (GSK) vaccine showed moderate efficacy against clinical malaria. We aimed to identify RTS,S/AS01-induced signatures associated with clinical malaria by analyzing antigen-stimulated peripheral blood mononuclear cells sampled from a subset of trial participants at baseline and month 3 (one month post-third dose). RTS,S/AS01 vaccination was associated wit...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0a659a7c-2d69-55ea-8927-4a85cb42b8c9
- DOI
- 10.1101/2021.05.19.21257227
